Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Bites and Stings 1

Interventions

pembrolizumab 3blinatumomab 2enzalutamide 1durvalumab 1dostarlimab 1cemiplimab 1atezolizumab 1abiraterone 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Immune Checkpoint Inhibitors 1Hydroxyurea 1Etoposide 1Etanercept 1Cytochrome P-450 Enzyme System 1Carboplatin 1AMG 757 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Bites and Stings × Cytochrome P-450 Enzyme System × Clear all
NCT03792841 2025-10-16

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Amgen

Phase 1 Terminated
212 enrolled
Genitourinary

Bites and Stings, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡